OBI Pharma has received clearance from the US FDA for an IND application for OBI-902 to begin a Phase I/II trial for advanced ...

Veraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) ...

Starting at 7:30 p.m. inside the Providence Farm Chapel, the show is an entirely acoustic, unplugged, candlelit performance.

Students stroll into the classroom on a sunny afternoon. They fall into their assigned seats, open their laptops, and lean in ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in poster format at the American Association ...

The FDA's Fast Track designation has potential to accelerate drug development and review process for ADRX-0706 ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have ...

OBI's Chief Executive Officer, Heidi Wang, Ph.D. noted, "The impending OBI-902-001 clinical trial intends to evaluate the ...

WASHINGTON, May 4 (Reuters) - President Donald Trump said he was unsure whether people in the U.S. are entitled to due process rights guaranteed in the U.S. Constitution as his administration ...

TAIPEI, Taiwan, May 01, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (“OBI”), a clinical stage oncology company（4174.TWO), today announced that the U.S. Food and Drug Administration (FDA） has ...